Purchases and Sales Made in Q4 2021 in Pacira Bio Sciences, Inc. (PCRX)
This table provides information about the institutional ownership of Pacira Bio Sciences, Inc. (PCRX) during Q4 2021. The information is specifically focused on institutions that hold shares of Pacira BioSciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Tamarack Advisers, LP
Carlsbad, CA |
SELL
|
- |
-135K- 36.0% |
$6.48M - $8.4M
|
240K
$4.67M
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-259K- 59.46% |
$12.4M - $16.1M
|
177K
$3.44M
|
|
|
Feb 11, 2022
Q4 2021
|
Neumeier Poma Investment Counsel LLC
|
SELL
|
- |
-294K- 47.3% |
$14.1M - $18.3M
|
328K
$6.38M
|
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-326K- 79.71% |
$15.6M - $20.3M
|
82.9K
$1.61M
|
|
|
Feb 14, 2022
Q4 2021
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-371K- 38.35% |
$17.8M - $23.1M
|
596K
$11.6M
|